Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Radiother Oncol. 2022 Jan 29;168:46–52. doi: 10.1016/j.radonc.2022.01.016

Figure 3: Recurrence free survival following proton radiotherapy for pediatric Hodgkin lymphoma.

Figure 3:

Only 5 patients relapsed over a median follow-up of 5.3 years and all recurrences were both within and outside of the initial treatment field. There were no marginal recurrences. The 5-year recurrence free survival was 90%.